COLLEEN BLANCHFIELD: Open Payments
NPI 1558581314 · RESTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,861 in 27 payments from 9 companies in 2025. Trend: 2023 $714 · 2024 $323 · 2025 $6,861
Honoraria: $6,050Food & beverage: $618Travel & lodging: $123Education: $70
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $6,445 |
| Alkermes, Inc. | 7 | $140 |
| HARMONY BIOSCIENCES LLC | 2 | $95 |
| ABBVIE INC. | 3 | $72 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| TMS NeuroHealth Centers Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: Auvelity, ARISTADA, QULIPTA, FANAPT, UBRELVY, WAKIX, SPRAVATO, REXULTI.
Industry payments across VA — which companies pay providers there.
